Skip to main content
Top
Published in: Globalization and Health 1/2016

Open Access 01-12-2016 | Research

Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data

Authors: Heleen Vermandere, Marie-Anne van Stam, Violet Naanyu, Kristien Michielsen, Olivier Degomme, Frans Oort

Published in: Globalization and Health | Issue 1/2016

Login to get access

Abstract

Background

Many studies investigate HPV vaccine acceptability, applying health behavior theories to identify determinants; few include real uptake, the final variable of interest. This study investigated the utility of the Health Belief Model (HBM) in predicting HPV vaccine uptake in Kenya, focusing on the importance of promotion, probing willingness to vaccinate as precursor of uptake and exploring the added value of personal characteristics.

Methods

Longitudinal data were collected before and after a pilot HPV vaccination program in Eldoret among mothers of eligible girls (N = 255). Through pathway modeling, associations between vaccine uptake and the HBM constructs, willingness to vaccinate and adequate promotion were examined. Adequate promotion was defined as a personal evaluation of promotional information received. Finally, baseline cervical cancer awareness and socio-demographic variables were added to the model verifying their direct, mediating or moderating effects on the predictive value of the HBM.

Results

Perceiving yourself as adequately informed at follow-up was the strongest determinant of vaccine uptake. HBM constructs (susceptibility, self-efficacy and foreseeing father’s refusal as barrier) only influenced willingness to vaccinate, which was not correlated with vaccination. Baseline awareness of cervical cancer predicted uptake.

Conclusions

The association between adequate promotion and vaccination reveals the importance of triggers beyond personal control. Adoption of new health behaviors might be more determined by organizational variables, such as promotion, than by prior personal beliefs. Assessing users’ and non-users’ perspectives during and after implementing a vaccination program can help identifying stronger determinants of vaccination behavior.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO ICO. Human Papillomavirus and Related Cancers. Kenya. Summary Report Update. 2015. WHO ICO. Human Papillomavirus and Related Cancers. Kenya. Summary Report Update. 2015.
2.
go back to reference Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–14. doi:10.1016/s0140-6736(09)61248-4.CrossRefPubMed Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–14. doi:10.​1016/​s0140-6736(09)61248-4.CrossRefPubMed
3.
go back to reference The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;256(19):1915–27. The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;256(19):1915–27.
10.
go back to reference Dempsey AF. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93. doi:10.1542/peds.2005-1381.CrossRefPubMed Dempsey AF. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486–93. doi:10.​1542/​peds.​2005-1381.CrossRefPubMed
17.
go back to reference Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–86.CrossRef Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–86.CrossRef
18.
go back to reference Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175–83.CrossRefPubMed Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175–83.CrossRefPubMed
19.
20.
go back to reference Champion VL, Skinner SR. The health belief model. Health behavior and health education: theory, research and practice. Fourthth ed. 2008. Champion VL, Skinner SR. The health belief model. Health behavior and health education: theory, research and practice. Fourthth ed. 2008.
31.
go back to reference Francis JJ, Eccles MP, Johnston M, Walker A, Grimshaw J, Foy E, et al. Constructing questionnaires based on the Theory of Planned Behaviour. A manual for health services researchers. 2004. ISBN: 0-9540161-5-7. Francis JJ, Eccles MP, Johnston M, Walker A, Grimshaw J, Foy E, et al. Constructing questionnaires based on the Theory of Planned Behaviour. A manual for health services researchers. 2004. ISBN: 0-9540161-5-7.
32.
go back to reference Peterson RA. A meta-analysis of cronbach’s coefficient alpha. J Consum Res. 1994;21:381–91.CrossRef Peterson RA. A meta-analysis of cronbach’s coefficient alpha. J Consum Res. 1994;21:381–91.CrossRef
33.
go back to reference Muthén B. A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika. 1984;49:115–32.CrossRef Muthén B. A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika. 1984;49:115–32.CrossRef
34.
go back to reference Kline RB. Principles and Practice of Structural Equation Modeling. 3rd ed. New York: The Guilford Press; 2011. Kline RB. Principles and Practice of Structural Equation Modeling. 3rd ed. New York: The Guilford Press; 2011.
35.
go back to reference Newsom J. Practical approaches to dealing with nonnormal and categorical variables. 2005. Newsom J. Practical approaches to dealing with nonnormal and categorical variables. 2005.
38.
go back to reference Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt). 2009;18(10):1679–86. doi:10.1089/jwh.2008.1329.CrossRef Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt). 2009;18(10):1679–86. doi:10.​1089/​jwh.​2008.​1329.CrossRef
39.
go back to reference Brewer NT. A meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. 2005. Brewer NT. A meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. 2005.
42.
go back to reference Sturm LA, Mays RM, Zimet GD. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr. 2005;26(6):441–52.CrossRefPubMed Sturm LA, Mays RM, Zimet GD. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr. 2005;26(6):441–52.CrossRefPubMed
45.
go back to reference Bowyer HL, Forster AS, Marlow LA, Waller J. Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey. J Fam Plann Reprod Health Care. 2014;40(1):14–22. doi:10.1136/jfprhc-2013-100583.CrossRefPubMed Bowyer HL, Forster AS, Marlow LA, Waller J. Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey. J Fam Plann Reprod Health Care. 2014;40(1):14–22. doi:10.​1136/​jfprhc-2013-100583.CrossRefPubMed
46.
go back to reference Kumar S, Quinn SC, Kim KH, Musa D, Hilyard KM, Freimuth VS. The social ecological model as a framework for determinants of 2009 H1N1 influenza vaccine uptake in the United States. Health Educ Behav. 2012;39(2):229–43. doi:10.1177/1090198111415105.CrossRefPubMed Kumar S, Quinn SC, Kim KH, Musa D, Hilyard KM, Freimuth VS. The social ecological model as a framework for determinants of 2009 H1N1 influenza vaccine uptake in the United States. Health Educ Behav. 2012;39(2):229–43. doi:10.​1177/​1090198111415105​.CrossRefPubMed
Metadata
Title
Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
Authors
Heleen Vermandere
Marie-Anne van Stam
Violet Naanyu
Kristien Michielsen
Olivier Degomme
Frans Oort
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2016
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-016-0211-7

Other articles of this Issue 1/2016

Globalization and Health 1/2016 Go to the issue